| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |






From the Departments of Genetics,*
Dermatology,
and
Pathology,¶
Virgen de la Salud Hospital, Toledo;
and the Departments of Dermatology
and
Pathology,§
12 de Octubre Hospital,
Madrid, Spain
Mycosis fungoides is usually an indolent disease that, after a variable period of time in a stable phase, evolves into a tumoral form with aggressive behavior. The molecular events that mark this progression remain essentially unknown to date, and this prompted us to investigate the hypothetical role of p16INK4a silencing in mycosis fungoides progression. We analyzed the three most frequent mechanisms of inactivation of the p16INK4a gene (deletion, promoter hypermethylation, and mutation) in nine cases with patch/plaque and tumoral lesions of mycosis fungoides. The existence of alterations was investigated by microsatellite analysis, methylation-specific polymerase chain reaction, and direct sequencing. Alterations of the p16INK4a gene were found in four of nine of the plaque lesions (hypermethylation in three samples and allelic loss in one sample) and seven of nine in the tumor lesions (hypermethylation in five samples and allelic loss in three samples). No case presented point mutations. Although a higher incidence of p16INK4a hypermethylation was observed in the cases that failed to achieve a complete remission, the limited size of our series prompted us to evaluate this finding cautiously. The results of this study therefore showed a common genetic alteration that is found more frequently in tumoral lesions than it is in plaque lesions of mycosis fungoides. It also offers data that could suggest a relationship between p16INK4a hypermethylation and unfavorable clinical outcome. Broader studies are needed to confirm both relationships.
This article has been cited by other articles:
![]() |
R. van Doorn, M. S. van Kester, R. Dijkman, M. H. Vermeer, A. A. Mulder, K. Szuhai, J. Knijnenburg, J. M. Boer, R. Willemze, and C. P. Tensen Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome Blood, January 1, 2009; 113(1): 127 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, H. Y. Wang, A. Woetmann, P. N. Raghunath, N. Odum, and M. A. Wasik STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes Blood, August 1, 2006; 108(3): 1058 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Karenko, S. Hahtola, S. Paivinen, R. Karhu, S. Syrja, M. Kahkonen, B. Nedoszytko, S. Kytola, Y. Zhou, V. Blazevic, et al. Primary Cutaneous T-Cell Lymphomas Show a Deletion or Translocation Affecting NAV3, the Human UNC-53 Homologue Cancer Res., September 15, 2005; 65(18): 8101 - 8110. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Doorn, W. H. Zoutman, R. Dijkman, R. X. de Menezes, S. Commandeur, A. A. Mulder, P. A. van der Velden, M. H. Vermeer, R. Willemze, P. S. Yan, et al. Epigenetic Profiling of Cutaneous T-Cell Lymphoma: Promoter Hypermethylation of Multiple Tumor Suppressor Genes Including BCL7a, PTPRG, and p73 J. Clin. Oncol., June 10, 2005; 23(17): 3886 - 3896. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tracey, R. Villuendas, A. M. Dotor, I. Spiteri, P. Ortiz, J. F. Garcia, J. L. R. Peralto, M. Lawler, and M. A. Piris Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study Blood, August 1, 2003; 102(3): 1042 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zettl, G. Ott, A. Makulik, T. Katzenberger, P. Starostik, T. Eichler, B. Puppe, M. Bentz, H. K. Muller-Hermelink, and A. Chott Chromosomal Gains at 9q Characterize Enteropathy-Type T-Cell Lymphoma Am. J. Pathol., November 1, 2002; 161(5): 1635 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Kadin T-Cell Clonality in Pityriasis Lichenoides: Evidence for a Premalignant or Reactive Immune Disorder? Arch Dermatol, August 1, 2002; 138(8): 1089 - 1090. [Full Text] [PDF] |
||||
![]() |
M. H. Vermeer, C. P. Tensen, P. M. van der Stoop, H. W. van Oostveen, M. Lund, R. J. Scheper, and R. Willemze Absence of TH2 Cytokine Messenger RNA Expression in CD30-Negative Primary Cutaneous Large T-Cell Lymphomas Arch Dermatol, July 1, 2001; 137(7): 901 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, D. T. Ross, M. E. Kadin, P. O. Brown, and M. A. Wasik Comparative Genome-Scale Analysis of Gene Expression Profiles in T Cell Lymphoma Cells during Malignant Progression Using a Complementary DNA Microarray Am. J. Pathol., April 1, 2001; 158(4): 1231 - 1237. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |